Ultrastructure of mouse peritoneal cells engaged in spontaneous secretion of antibody against mouse and sheep erythrocytes and evolution of cell types during culture.

Pretreatment of Strain 2 and Strain 13 guinea pigs with guinea pig thyroglobulin (GPTG)² in incomplete Freund's adjuvant (IFA) reduced both the incidence and severity of experimental autoimmune thyroiditis (EAT) in animals subsequently challenged with GPTG in complete Freund's adjuvant (CFA). Antithyroglobulin antibody titers were reduced by pretreatment with GPTG in IFA in some, but not all, experiments while delayed hypersensitivity to GPTG was not affected. The suppressive effect induced by antigen pretreatment was transferrable by lymphoid cells but not by serum from pretreated animals.     

Influence of heparin and protamine on enlargement of the draining lymph node during induction of EAE

Popliteal lymph node enlargement four days after immunization with encephalitogenic guinea pig basic protein in Freund's complete adjuvant (EGPBP-FCA) was less in heparin treated and greater in protamine-treated Lewis rats than in salineinjected controls. These agents were without influence on the node enlargement occasioned by Freund's adjuvant alone or on node size in nonimmunized rats. Decreased cell trapping in the node in heparinized rats and increased trapping in protamine-treated rats immunized with EGPBP-FCA is suggested.     

Suppression of experimental autoimmune thyroiditis in guinea pigs by pretreatment with thyroglobulin-coupled spleen cells

Pretreatment of Strain 2 and Strain 13 guinea pigs with guinea pig thyroglobulin (GPTG) coupled to syngeneic spleen cells (GPTG-SC) suppressed the development of experimental autoimmune thyroiditis (EAT) induced by immunization with GPTG in complete Freund's adjuvant (CFA). Antibody titers to GPTG were only minimally suppressed in GPTG-SC pretreated animals. GPTG-SC also suppressed the sensitization of periotneal exudate T lymphocytes which proliferate in vitro in the presence of GPTG.     

Specific depression of delayed hypersensitivity to purified proteins, with relation to production of circulating antibody

In guinea pigs sensitized in the footpads with a purified protein, such as hen egg albumin or diphtheria toxoid, in incomplete Freund's adjuvant, delayed hypersensitivity precedes the appearance of circulating antibody. This expression of delayed hypersensitivity by skin-test declines sharply the day before circulating antibody is detected. Adoptive transfer of spleen and peritoneal exudate cells from guinea pigs showing this decline suppresses the expression of delayed hypersensitivity in already sensitized recipients. This suppression of delayed hypersensitivity is immunologically specific. The intensity of this suppression does not correlate directly with the dose of sensitizing antigen, nor does it depend directly on the amount of circulating antibody.     

A comparison of peritoneal exudate cells and peripheral blood leukocytes in direct and indirect migration inhibition tests as in vitro assays for tuberculin hypersensitivity in guinea pigs.

Peritoneal exudate cells (PEC) and peripheral blood leukocytes (PBL) are most frequently used in the migration inhibition test. The aim o this work was to compare the ability of these two types of cells to reflect tuberculin hypersensitivity in the migration inhibition test. We sensitized 36 guinea pigs with complete Freund's adjuvant and 20 controls were injected with incomplete Freund's adjuvant. Migration of PEC in medium containing 5, 15, or 75 μg of PPD/ml was assessed after 30 min, and 1, 2, 4, 18, 24, and 48 hr of incubation. The migration of PEC from sensitized animals was inhibited, the inhibition being dose dependent and, with lower concentrations of the antigen, becoming significant only after 4 hr or later. With both PEC and PBL from the same sensitized animal we observed virtually identical migration inhibition in the presence of 75 μg of PPD/ml. A correlation was found between the migration inhibition indices of PEC and PBL. In the indirect test, active supernatants containing lymphokines caused nearly identical migration inhibition of PEC and PBL from normal animals. It follows that in the guinea pig PEC and PBL behave alike both in the direct and in the indirect migration inhibition tests. Thus, PEC and PBL appear to be equally valuable sources of cells for migration inhibition tests.     

Comparability of delayed hypersensitivity in various rodents. I. Regulatory mechanism of delayed footpad reactions in the hamster

A relationship between delayed footpad reaction and antibody production was observed in hamsters immunized with erythrocytes of the mouse (MRC), sheep (SRC), or chicken (CRC). (i) In hamsters immunized with MRC in incomplete Freund's adjuvant (IFA), delayed reactions were positive in spite of high titers of IgM. Delayed reactions became negative with the appearance of IgG in hamsters pretreated with mouse spleen cells. (ii) In those immunized with SRC in IFA, positive delayed reactions were elicited only in the absence of IgG. Delayed reactions were converted from negative to positive by treatment with cyclophosphamide before elicitation in the presence of IgG. (iii) After immunization with SRC in complete Freund's adjuvant (CFA) or CRC in IFA or CFA, positive delayed reactions were elicited in the presence of IgG. There may exist an unstable form of delayed footpad reactions, which is regulated by antibody production, and a stable form, which is not regulated. Suppression in the former may be ascribed to some mechanism which is sensitive to cyclophosphamide and may be related to the production of IgG but not IgM.     

Experimental allergic encephalomyelitis and cellular immunity in the Lewis rat

The encephalitogenic difference between purified guinea pig and bovine myelin proteins in the Lewis rat is reflected by the two molecules' lack of crossreactivity in the migration inhibition test. Peritoneal exudate cells from rats injected with guinea pig or bovine derived myelin basic protein in Freund's complete adjuvant demonstrate substantial migration inhibition to the sensitizing antigen but little inhibition when cultured in the presence of the other basic protein. The cellular reactivity to guinea pig basic protein is present throughout the induction phase of Experimental Allergic Encephalomyelitis and persists after the recovery of the rats from the paralytic state. Substantial cellular reactivity is also demonstrated to bovine basic protein even though this molecule shows minimal encephalitogenic activity in the Lewis rat. Minimal lymphocyte transformation could be demonstrated to either of the basic proteins, although the immune cells react strongly to the plant mitogen phytohemagglutinin and to a Mycobacterium tuberculosis antigen.     

Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism

Protection against experimental autoimmune encephalomyelitis (EAE) was studied in the guinea pig and the Lewis rat. Basic protein of myelin (BPM) injected in incomplete Freund's adjuvant (IFA) gave solid protection against subsequent challenge with normally encephalitogenic doses of BPM in complete Freund's adjuvant (CFA). Protection depended on the amount of BPM in IFA injected and on the duration of the interval between protection and encephalitogenic challenge with BPM in CFA. Notably, protection was long lasting; it remained demonstrable, to some degree for 52 weeks in guinea pig and 32 weeks in rats, these being the longest intervals tested.Protection could not be correlated with serum antibody levels to BPM, and was afforded in the guinea pig by the injection, in IFA, of a synthetic peptide matching residues 112–122 of human BPM; this peptide produced no detectable serum antibody to BPM. Protected guinea pigs had intact cell-mediated immunity to BPM, as measured by inhibition of macrophage migration in vitro. The mechanism of protection may involve the production, following injection of BPM in IFA, of a class of suppressor thymic lymphocytes capable of overriding otherwise encephalitogenic thymic lymphocytes.     

Induction of delayed-type hypersensitivity with proteins made insoluble by polymerization

Protein antigens, made particulate by polymerization with ethyl chloroformate, were incorporated in Freund's complete adjuvant and used for footpad immunization of rats and guinea pigs. A comparison was made with animals similarly immunized with the native, soluble protein. Two to three weeks after immunization of rats with polymerized bovine serum albumin (Pol-BSA) and up to 8 weeks after immunization of guinea pigs with polymerized diphtheria toxoid, in vivo and in vitro evidence of delayed-type hypersensitivity (DTH) was found without measurable serum antibodies. Ten times more polymerized than soluble BSA was needed to induce comparable levels of DTH. This was not, however, true in the case of serum antibodies, since soluble BSA induced higher titers than the 1000 times larger amount of Pol-BSA. In addition, the titers in polymer-immunized rats were consistently low or under detectable level when followed up to 5 months after priming. These findings encourage the belief that insolubilization of antigens by polymerization guides the immune response toward cell-mediated immunity, whereas antibody formation becomes weaker. However, boosting of polymer-primed animals with soluble antigen resulted in the production of high levels of antibody.     

Durability of immune protection against experimental autoimmune encephalomyelitis.

The durability of immunoprotection against experimental autoimmune encephalomyelitis (EAE) was assessed in guinea-pigs, using a standard protective inoculum (10 μg) of basic protein of myelin (BPM) in Freund's incomplete adjuvant. Protected animals withstood incrementally greater challenges with BPM in Freund's complete adjuvant, up to the massive dose of 10 mg. Protection was not readily overridden by challenge with either whole human brain or guinea-pig spinal cord, indicating that BPM is the major if not only encephalitogen in neural tissue. Protected animals, after encephalitogenic challenge, either developed no disease or a mild attenuated form of EAE; a few developed either chronic or relapsing types of EAE.Immunoprotection correlated with reduced cell-mediated immunity to BPM as judged by cutaneous reactions, but not with humoral antibodies to BPM as detected by radioimmunoassay (total antibody) or passive cutaneous anaphylaxis (IgG₁ class); total and IgG₁ antibody increased with repetitive encephalitogenic challenge. Whilst immunoprotection is related to functional changes in T cells, it remains uncertain whether there is potentiation of a class of suppressor T cells, or inhibition of a class of cytotoxic T cells, or both.     

Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components.

Synthetic N-acetyl-muramyl-l-alanyl-d-isoglutamine represents the minimal structure capable of duplicating the activity of mycobacteria in Freund's complete adjuvant. In contrast to mycobacterial adjuvant preparations, that function only in the form of water-in-oil emulsions, this compound and a second synthetic analog (N-acetyl-muramyl-l-alanyl-d-isoglutamic acid) augment the humoral immune responses of mice equally as well as aqueous solutions. Whereas N-acetyl-muramyl-l-alanyl-d-isoglutamic acid administered to guinea pigs in water-in-oil emulsion has no effect, N-acetyl-muramyl-l-alanyl-d-isoglutamine induces delayed hypersensitivity to ovalbumin and azobenezene-arsonate N-acetyl-l-tyrosine and increases the level of antibody against ovalbumin. Under these conditions, challenge with the synthetic adjuvants themselves evokes no skin responses. Moreover, Freund's complete adjuvant sensitizes guinea pigs to tuberculin and to native mycobacterial water-soluble adjuvant but not to the synthetic analogs.     

Potentiation and modulation of the immune response of guinea pigs to poorly immunogenic protein-hapten conjugates by pretreatment with the MER fraction of attenuated tubercle bacilli

The MER fraction of attenuated tubercle bacilli of the BCG strain was shown capable of stimulating and modulating the immunological responsiveness of guinea pigs to immunization with DNP conjugates of allogeneic globulin (DNP-GPG) and xenogeneic albumin (DNP-HSA). These antigens are very poorly immunogenic and fail to evoke detectable immune responses following single administration alone.When incorporated in incomplete Freund's adjuvant (IFA) together with the conjugates, MER could substitute for whole tubercle bacilli in the adjuvant mixture, and cause the conjugates to evoke both cellular and humoral reactivity, the former indicated by the development of skin reactions of delayed type (DH) to test injections of the antigens, the latter by the formation of humoral antibodies detected by an indirect hemagglutination (HA) test. When administered in saline together with antigen, MER was ineffective.Pretreatment with MER by any of several different routes 7 or 14 days prior to sensitization enabled a large number of the animals to respond with either DH, circulating antibody formation, or both. Under similar circumstances, pretreatment with Freund's complete adjuvant (FCA) elicited no such preparatory effect. In order to be efficacious in pretreatment, MER had to be given in a saline suspension; activity was lost when it was applied in IFA.MER pretreatment modulated the immune response to subsequent sensitization with the conjugates preferentially towards DH or antibody production, depending on the parameters of treatment and specific immunization. It appeared that when the specific immunogenic stimulus was weak, pretreatment with MER strongly favored DH.     

Abrogation of resistance to the reinduction of experimental allergic encephalomyelitis by pertussigen

Experimental allergic encephalomyelitis is an autoimmune disease initiated by an injection of myelin basic protein in complete Freund's adjuvant. Lewis rats which have recovered from the initial episode of hindquarter paralysis are resistant for at least 6 months to disease reinduction by basic protein-complete Freund's adjuvant, although specific antigen-reactive cells are detectable in convalescent rats. Resistance cannot be attributed to the activity of the adjuvant alone. In contrast, clinical disease could be reinduced by a secondary challenge with spinal cord homogenate and pertussigen (“lymphocytosis promoting factor” of Bordetella pertussis). Disease could also be reinduced by a simultaneous secondary challenge with basic protein-complete Freund's adjuvant along with pertussigen. Vascular permeability increases in the spinal cord paralleled disease induction or reinduction. No definite conclusions can be drawn concerning the mechanism by which pertussigen promotes disease reinduction in convalescent rats.     

The induction of at least two distinct types of interferon in mouse spleen cell cultures by Corynebacterium parvum

Mice immunized with particulate antigens or soluble antigens in Freund's complete adjuvant produce a factor(s) which enhances antibody formation. Such an enhancing factor(s) is detected in the serum within 6 hr after immunization. The factor(s) is specific and enhances both 19s and 7s responses especially when recipient mice are challenged with subimmunogenic doses of antigen. From the study of the kinetics of antibody formation (latent period, coincidence of peaks of 19s and 7s responses) and the distribution of the Ig classes of the antibody (dominance of IgG1) it is concluded that the enhancing factor(s) primes the animals for a secondary response. The enhancing factor(s) is carrier specific and enhances antibody formation in the absence of T cells (nude mice). In the absence of T cells the antibody response is quantitatively small, which suggests that in the presence of T cells the enhancing factor(s) further amplifies antibody formation.     

The role of myelin lipids in experimental allergic encephalomyelitis. III. Transfer of suppression from guinea pigs recovering from EAE, induced by myelin basic protein--galactocerebroside complexes

Juvenile strain 13 guinea pigs were immunized with myelin basic protein (MBP) combined with galactocerebrosides (MBP + GC) or with total myelin lipids without GC [MBP + (TL-GC)] in CFA. Control animals received dinitrophenylated-ovalbumin (DNP-OA) in CFA, CFA or IFA alone. The animals injected with MBP + GC showed a higher rate of recovery from the first EAE episode (83%) than those treated with MBP + (TL-GC) (50%). With the exception of the group treated with IFA alone, all animals were refractory to EAE following rechallenge with MBP in CFA 90 days after the first exposure. The in vitro proliferative response to MBP, of peripheral blood lymphocytes (PBLs) derived from guinea pigs freshly sensitized to MBP in CFA, was drastically suppressed in the presence of PBLs from animals injected with MBP + GC. Upon transfer to normal syngeneic recipients, spleen cells from MBP + GC-treated animals completely suppressed the clinical and histological manifestations of EAE following recipient challenge with MBP in CFA. Cell-free supernatants from PBLs and spleen cells of strain 13 guinea pigs treated with MBP + GC inhibited lymphocyte proliferation to MBP, of allogeneic responder cells, and spleen cell supernatants completely suppressed the induction of EAE upon transfer to allogeneic recipients. Suppression could not be transferred with cells from other treated groups. These results suggest that animals immunized with MBP + galactocerebrosides in CFA develop suppressor cells that may be in part responsible for the recovery from the first EAE episode and for protection against rechallenge with MBP in CFA. Their cell-free supernatants act in an MHC-nonrestricted fashion. These results do not rule out an additional protective mechanism since all animals exposed to CFA were refractory to rechallenge despite lack of demonstrable suppressor cell activity.     

Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides

We recently demonstrated that Lewis rats immunized with bacterial lipopolysaccharides (LPS) precomplexed to guinea pig myelin basic protein (BP) in complete Freund's adjuvant were less effective in inducing experimental allergic encephalomyelitis (EAE) than BP-immunized controls. When tested in vitro both lymph node cells (LNC) and spleen cells (SpC) of animals immunized with BP-LPS were less effective in proliferative responses to various mitogens, which included phytohemagglutinin, concanavalin A, purified protein derivative of tuberculin, LPS, and BP. Of importance immunization of rats with BP complexed to LPS results in the generation of cells in lymph nodes of these animals that suppress the mitogenic response of BP-immunized LNC and also SpC in mixed lymphocyte cultures. The suppressive effect of these cells in mixed lymphocyte culture reaction was found specifically in response to BP and to a lesser extent to LPS in LNC. SpC of BP-LPS immunized animals did not suppress the proliferative response to SpC of BP-immunized animals. Treatment of these LNC with antithymocyte serum and complement abolished this suppressive effect of LNC, suggesting that the immunoregulatory cells in LNC of BP-LPS immunized animals are suppressor T lymphocytes. The parallel between the in vitro induction of suppressor T lymphocytes in the draining LNC and the function of LPS in the development of EAE in Lewis rats suggests a possible immunologic significance of the effect.     

Factors involved in the production of specific antibodies to estriol and estradiol

To determine what effect the site of attachment of the hapten would have on specificity, 6-oxoestrogens were synthesized and conjugated to several carrier proteins, using the mixed anhydride formed between isobutyl chloroformate and the steroid 6-oxime. Estriol was also treated with phosgene to produce a mixture of chloroformates followed by conjugation to bovine serum albumin. Rabbits were immunized, and the specificity of the anti-sera produced was established by cross-reaction measurements, using both direct binding and binding inhibitor assays. Comparison of the immune response showed that antibodies to the randomly linked estriol chloroformate had a high degree of cross-reactivity with estrone and estradiol (30–100%), while those produced to 6-oxo linked estriol showed only a 1–12% cross-reaction. Similar results were obtained for estradiol antibodies. Comparison of antibody formation and specificity of 6-oxoestriol linked to a polylysine copolymer, bovine serum albumin or rabbit serum albumin was made. Also, the antigen was given with complete Freund's adjuvant, adsorbed onto charcoal, entrapped within polyaery lamide gel or in vivo titrated with estrogen implants. Only estrogen specifically linked to bovine serum albumin in Freund's adjuvant gave satisfactory results, while the others yielded antibodies of decreasing titers or low specificity.It is concluded that specificity and titers seem to depend not only on the site of conjugation but also on the carrier, immunization procedure and certain other factors.     

Mechanisms of suppressed cell-mediated immunity and impaired antigen-induced interleukin 2 production in granuloma-bearing mice

Pulmonary granulomas were induced in BALB/c mice immunized with methylated bovine serum albumin in complete Freund's adjuvant by the intratracheal injection of plain agarose beads or beads conjugated to specific antigen. Large hypersensitivity granulomas developed around antigen-coupled beads in immunized animals. Smaller but still prominent granulomatous reactions developed around plain beads in immunized mice. In nonimmunized animals, both plain and antigen conjugated beads produced very small granulomas. Granuloma formation in sensitized animals was associated with suppressed delayed-type hypersensitivity reactions induced by the footpad injection of specific and nonspecific antigens. Lymph node cells from sensitized granuloma-bearing mice with cutaneous anergy showed suppressed specific and nonspecific antigen-induced proliferative responses in vitro. These cells also showed suppressed interleukin 2 production in response to specific antigen. Although no soluble suppressive factor was detected in granuloma extracts, suppressor cells were found in lymph nodes of granuloma-bearing mice, which could inhibit antigen-induced production of interleukin 2 by lymph node cells from immunized mice. Antigen-specific immunoglobulin G antibody production was not suppressed in immunized granuloma-bearing mice. Previous studies from our laboratory have demonstrated migration inhibition factor and interleukin 1 activities in aqueous extracts prepared from granuloma-bearing lungs of immunized mice. These results and the findings reported here indicate that granuloma formation and the associated anergy observed in this system are primarily expressions of cell-mediated immunity; selective suppression of in vivo and in vitro expressions of cell-mediated immunity in granuloma-bearing mice may be due to impaired antigen-induced interleukin 2 production; and such impairment is caused by suppressor cells.     

Immune responses to myelin basic protein in mycobacterial-induced suppression of experimental allergic encephalomyelitis

Pretreatment of guinea pigs with complete Freund's adjuvant (CFA) 21 days prior to injection with myelin basic protein (BP) in CFA resulted in marked attenuation of clinical and pathologic manifestations of experimental allergic encephalomyelitis (EAE). Delayed hypersensitivity skin tests to homologous BP were likewise depressed in protected animals. The protected guinea pigs also demonstrated diminished in vitro reactivity to BP as assessed by BP-induced proliferative response of peritoneal exudate cells (PEC) and BP-induced inhibition of macrophage migration. Broad-based suppression of immunologic reactivity did not occur in these animals, as manifested by larger skin tests to PPD, a greater proliferative response to old tuberculin (OT), by PEC and peripheral blood lymphocytes (PBL), as well as marked PPD-induced inhibition of macrophage migration. Diminution of the degree of cell-mediated reactivity to BP may be one of the mechanisms by which prior treatment with CFA suppresses subsequent development of EAE.     

In vitro response to basic protein in experimental allergic encephalomyelitis: effect of pretreatment with basic protein in incomplete adjuvant

Guinea pigs injected with myelin basic protein (BP) in incomplete Freund's adjuvant (IFA) fail to develop experimental allergic encephalomyelitis (EAE) after challenge with BP in complete Freund's adjuvant (CFA). Such protected animals fail to manifest significant in vitro lymphocyte proliferative responses to BP 13 days after BP/CFA in comparison to animals with EAE. Other BP/IFA-BP/CFA animals develop significant albeit modest responses to BP 21 and 28 days after BP/CFA but do not develop EAE. There was little effect on the response to tuberculin (OT). Guinea pigs receiving only BP/IFA develop a modest transient reactivity to BP and no EAE. CFA alone after BP/IFA elicits a normal response to OT and has no effect on the response to BP.